Skip to main content
Livermore
Livermore
ZHEN

KBC Group NV

SEC CIK
0001411133
Latest filing
Aug 5, 2026

ABT holding history

Abbott Laboratories in every 13F filed by KBC Group NV, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
971,537
Value
$88.2M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of ABT by KBC Group NV, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026971,537$88.2M0.2%−14,573−1.5%ReducedHolders
Q1 2026986,110$101.2M0.3%−1,334,196−57.5%ReducedHolders
Q4 20252,320,306$430.4M1.0%+1,299,294+127.3%AddedHolders
Q3 20251,021,012$136.8M0.3%+74,749+7.9%AddedHolders
Q2 2025946,263$128.7M0.3%+281,188+42.3%AddedHolders
Q1 2025665,075$88.2M0.3%−297,537−30.9%ReducedHolders
Q4 2024962,612$108.9M0.3%−535,135−35.7%ReducedHolders
Q3 20241,497,747$170.8M0.5%+570,224+61.5%AddedHolders
Q2 2024927,523$96.4M0.3%−94,772−9.3%ReducedHolders
Q1 20241,022,295$116.2M0.4%−495,390−32.6%ReducedHolders
Q4 20231,517,685$167.1M0.6%−261,797−14.7%ReducedHolders
Q3 20231,779,482$172.3M0.7%+81,517+4.8%AddedHolders
Q2 20231,697,965$185.1M0.8%−52,551−3.0%ReducedHolders
Q1 20231,750,516$177.3M0.8%+278,451+18.9%AddedHolders
Q4 20221,472,065$161.6M0.8%−13,777−0.9%ReducedHolders
Q3 20221,485,842$143.8M0.7%+35,400+2.4%AddedHolders
Q2 20221,450,442$157.6M0.8%+459,331+46.3%AddedHolders
Q1 2022991,111$117.3M0.5%−383,159−27.9%ReducedHolders
Q4 20211,374,270$193.4M0.6%+390,506+39.7%AddedHolders
Q3 2021983,764$116.2M0.4%−150,463−13.3%ReducedHolders
Q2 20211,134,227$131.5M0.5%−101,879−8.2%ReducedHolders
Q1 20211,236,106$148.1M0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.